Personal tools

ETP Nanomedicine Newsletter Nr. 1/2010


29 January 2010

 

 ETPN_logoweb_1

Content of Issue:

ETP Nanomedicine elects new Executive Board

We are proud to announce that the new Executive Boar of the ETP Nanomedicine has been elected. Elections took place in December 2009. All nominated candidates have been elected. The new Executive Board is composed of the following chairpersons (see also >>>here):

  • ETPN Chairperson: Mr. Bertrand Loubaton from GE Healthcare Europe
  • ETPN Vice-chairperson: Dr. Juergen Simon from Siemens Healthcare
  • WG Nanodiagnostics chairperson: Mr. Patrick Boisseau from CEA-Leti
  • WG Drug Delivery chairperson: Prof. Mike Eaton from UCB Celltech
  • WG Regenerative Medicine chairperson: Mr. Jorge Alemany from Cellerix
  • Advisory Group ELSA: Dr. Klaus-Michael Weltring from Bioanalytik Muenster
  • Advisory Group IP: Mrs. Maaike van Velzen from Philips
  • Advisory Group RA: Dr. Joan-Albert Vericat from Zeltia

Congratulations to all of them! We are looking forward to another period of prosperous growth of the ETP Nanomedicine.
To see the voting results in detail please follow this link.
>> http://www.etp-nanomedicine.eu/internal/news-events/announcements/091215_ExBo_Election_Results.pdf

For further information on the Executive Board follow this link.

>> http://www.etp-nanomedicine.eu/public/about/objectives-mission/executive-board

European Commission Public Consultation on Nanotechnologies

TOWARDS A STRATEGIC NANOTECHNOLOGY ACTION PLAN (SNAP) 2010-2015

EU LOGOThe Commission intends to publish in 2010 a new strategic plan for EU actions related to nanotechnologies in the next five years. A Public Consultation is currently open in which experts as well as the public at large are invited to give their views on the needs for such EU action.

Objective of the consultation

Nanotechnologies hold great potential in areas as diverse as health, energy production and efficiency, transport and manufacturing. The Commission is considering a new Action Plan for Nanotechnology, addressing the technological and societal challenges of the next five years and strengthening the research and innovation efforts, with increased emphasis on sustainable development, competitiveness, health, safety and environmental issues.

The objective of this public consultation is to invite views on the needs in nanotechnology in the next five years, as perceived by experts active in the field and by the public at large.

This consultation is accessible via http://ec.europa.eu/research/consultations/snap/consultation_en.htm

Featured News

  • European Commission Public Consultation on Nanotechnologies
    TOWARDS A STRATEGIC NANOTECHNOLOGY ACTION PLAN (SNAP) 2010-2015
    Read more
  • Funding Opportunities for transnational research projects
    There are two new initiatives for funding SMEs: CORNET and EraSME. CORNET supports trans-national European co-operation between SME associations, SMEs and R&D performers. EraSME supports trans-national research co-operation between individual SMEs and RTOs.
    Read more
  • Nature - Review Article Materials engineering for immunomodulation
    The engineering of materials that can modulate the immune system is an emerging field that is developing alongside immunology...
    Read more
  • ETPN Expert Report 2009 published - Roadmaps in Nanomedicine
    The expert report elaborated by the ETP Nanomedicine together with the European Commission and the support of distinguished experts from academia and industry has been published.
    Read more
  • New LinkedIn Group "ETP Nanomedicine"
    A new LinkedIn group "ETP-Nanomedicine" has been created. It is open for all ETP Members.
    Read more

Upcoming Events

  • Regenerative Medicine: remedi For Success Conference
    With the strategic support of EPSRC, the remedi consortium has, over the last five years, built an international class capability in industry facing research and postgraduate education in Regenerative Medicine.
    Read more
  • Nanomedicine: Visions for the Future
    “Nanomedicine: Visions for the Future” is a two day conference. The growth of knowledge across all sciences, underpinned by equally rapid development in a range of enabling technologies such as nanotechnology, informatics and materials technologies, means that we are currently approaching a crossroads in medicine where medical practice will begin to focus much more on adapting innovative new treatments to the clinical needs of the individual patient, based both on the specific nature of their disease and their individual genomic and metabolomic profile.
    Read more
  • 3rd European Conference for Clinical Nanomedicine, Exhibition and University Village
    CLINAM is the conference platform in Europe for interdisciplinary debate between clinically oriented researchers, scientists and engineers from the diverse fields of medicine, physics, chemistry, pharmacy, biology, biochemistry and materials science.
    Read more

Job Offers

  • HEADS OF THE PRINCIPAL RESEARCH AREAS AND NANO-IMAGING RESEARCH FACILITY
    The future Andalusian Centre for Nanomedicine and Biotechnology (BIONAND) in Málaga (Spain) is seeking Heads for its main research areas: Nanodiagnostics, Therapeutic Nanosystems and Nanobiotechnology as well as for its Nano-Imaging Research Facility.
    Read more